肝特异性超声造影剂在肝细胞癌影像检查中的临床效用
本文综述超声造影在肝细胞癌临床路径中的作用,指出国际指南将增强CT和MRI作为诊断与分期的参考标准,而超声推荐用于高危人群筛查;纯血池超声造影剂因无法全肝成像及难以鉴别肝细胞癌与肝内胆管癌存在争议,Kupffer细胞窦状相造影剂可全肝成像并显示动脉期和门静脉期病变血管动力学。
要点
- 超声造影可高效诊断局灶性肝脏病变,纯血池造影剂能动态显示病变动脉期血管动力学。
- 国际学会对超声造影在肝细胞癌临床路径中的作用存在分歧。
- Kupffer细胞窦状相造影剂可经Kupffer细胞摄取实现全肝成像,并显示动脉期和门静脉期病变血管动力学。
核心结论
- 本综述旨在审视超声造影在肝细胞癌临床路径当前实践中的作用,并观察Kupffer细胞窦状相超声造影剂如何通过多模态、多造影剂方法补充当代诊断技术。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- 国际指南将增强CT和MRI认定为肝细胞癌诊断与分期的参考标准。
- 超声检查被推荐作为高危患者肝细胞癌的筛查工具。
临床应用与阅片要点
- 纯血池超声造影剂因无法持续进行全肝成像,被提示不足以将超声造影作为主要模态。
- 纯血池超声造影剂在鉴别肝细胞癌与肝内胆管癌方面的能力存在争议。
- Kupffer细胞窦状相超声造影剂可经Kupffer细胞摄取实现全肝成像,并显示动脉期和门静脉期病变血管动力学。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular carcinoma (HCC) is the most common form of hepatic malignancy, with high mortality rates recorded globally. Early detection through clinical biomarkers, medical imaging and histological assessment followed by rapid intervention are integral for positive patient outcomes. Although contrast-enhanced computed tomography scans and magnetic resonance imaging are recognised as the reference standard for the diagnosis and staging of HCC in international guidelines, ultrasound (US) examination is recommended as a screening tool for patients at risk. Contrast-enhanced US (CEUS) elevates the standard of an US examination using US contrast agents (UCAs), capable of diagnosing focal liver lesions with high efficacy. Most UCAs are purely intravascular, offering clinicians a dynamic representation of a lesions' arterial phase vascular kinetics, which is seldom seen in such detail during computed tomography or magnetic resonance imaging assessments. Despite its benefits, there is incongruity between international societies on the role of CEUS in the HCC clinical pathway. The transient nature of pure blood-pool agents is suggested to be insufficient to justify CEUS as a primary modality due to the inability to consistently perform whole liver imaging, alongside disputes regarding its capabilities to differentiate HCC from intrahepatic cholangiocarcinoma. A sinusoidal phase UCA affords clinicians the opportunity to perform whole liver imaging through Kupffer cell uptake in addition to visualising lesion vascular kinetics in the arterial and portal venous phases. Therefore, the purpose of this review was to examine the role of CEUS in the HCC clinical pathway in its current practice and observe how a Kupffer cell sinusoidal phase UCA may supplement contemporary diagnostic techniques through a multi-modality, multi-agent approach.
引用
- Hawley J, Tang Y, Sjöström A, et al. The Clinical Utility of Liver-Specific Ultrasound Contrast Agents During Hepatocellular Carcinoma Imaging. Ultrasound Med Biol. 2024. PMID: 39674715. doi:10.1016/j.ultrasmedbio.2024.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。